Farther Finance Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120K | Sell |
955
-172
| -15% | -$21.6K | ﹤0.01% | 1664 |
|
|
2025
Q1 | $149K | Sell |
1,127
-468
| -29% | -$61.8K | ﹤0.01% | 1346 |
|
|
2024
Q4 | $244K | Sell |
1,595
-6,061
| -79% | -$927K | 0.01% | 897 |
|
|
2024
Q3 | $1.48M | Buy |
7,656
+160
| +2% | +$31K | 0.06% | 255 |
|
|
2024
Q2 | $1.74M | Buy |
7,496
+426
| +6% | +$98.7K | 0.08% | 188 |
|
|
2024
Q1 | $1.52M | Sell |
7,070
-126
| -2% | -$27.1K | 0.09% | 186 |
|
|
2023
Q4 | $1.86M | Buy |
7,196
+6,018
| +511% | +$1.56M | 0.13% | 141 |
|
|
2023
Q3 | $303K | Buy |
1,178
+844
| +253% | +$217K | 0.05% | 290 |
|
|
2023
Q2 | $95.1K | Buy |
334
+145
| +77% | +$41.3K | 0.02% | 479 |
|
|
2023
Q1 | $52.5K | Buy |
189
+14
| +8% | +$3.89K | 0.02% | 590 |
|
|
2022
Q4 | $48.5K | Buy |
+175
| New | +$48.5K | 0.02% | 494 |
|